Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Targeted High-definition tDCS for Reducing Post-stroke Upper Limb Motor Impairments

NCT07599774 is registered in ClinicalTrials.gov with Carle Foundation Hospital as lead sponsor.

NCT NCT07599774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07599774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Targeted High-definition tDCS for Reducing Post-stroke Upper Limb Motor Impairments
Lead sponsor
Carle Foundation Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
June 30, 2027
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemiparetic stroke